- Publisher: Cambridge University Press
- Online publication date: July 2017
- Print publication year: 2017
- Online ISBN: 9781316717424
- Book DOI: https://doi.org/10.1017/9781316717424
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
Mark A. Lemley - William H. Neukom Professor, Stanford Law School, California
Sonia K. Katyal - Chancellor's Professor of Law, University of California, Berkeley
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
* Views captured on Cambridge Core between 13th July 2017 - 23rd August 2017. This data will be updated every 24 hours.